Virus-like Structures for Combination Antigen Protein MRNA Vaccination
Overview
Authors
Affiliations
Improved vaccination requires better delivery of antigens and activation of the natural immune response. Here we report a lipid nanoparticle system with the capacity to carry antigens, including mRNA and proteins, which is formed into a virus-like structure by surface decoration with spike proteins, demonstrating application against SARS-CoV-2 variants. The strategy uses S1 protein from Omicron BA.1 on the surface to deliver mRNA of S1 protein from XBB.1. The virus-like particle enables specific augmentation of mRNAs expressed in human respiratory epithelial cells and macrophages via the interaction the surface S1 protein with ACE2 or DC-SIGN receptors. Activation of macrophages and dendritic cells is demonstrated by the same receptor binding. The combination of protein and mRNA increases the antibody response in BALB/c mice compared with mRNA and protein vaccines alone. Our exploration of the mechanism of this robust immunity suggests it might involve cross-presentation to diverse subsets of dendritic cells ranging from activated innate immune signals to adaptive immune signals.
Zhang J, Zeng F, Li Y, Mu C, Liu C, Wang L Hum Vaccin Immunother. 2025; 21(1):2473183.
PMID: 40045463 PMC: 11901403. DOI: 10.1080/21645515.2025.2473183.
Review on the bioanalysis of non-virus-based gene therapeutics.
Zhou M, Zhang X, Yan H, Xing L, Tao Y, Shen L Bioanalysis. 2024; 16(23-24):1279-1294.
PMID: 39673530 PMC: 11703353. DOI: 10.1080/17576180.2024.2437418.
Bai L, Chen X, Li C, Zhou H, Li Y, Xiao J Drug Deliv. 2024; 31(1):2427138.
PMID: 39540234 PMC: 11565675. DOI: 10.1080/10717544.2024.2427138.
Virus-like structures for combination antigen protein mRNA vaccination.
Zhang J, Li Y, Zeng F, Mu C, Liu C, Wang L Nat Nanotechnol. 2024; 19(8):1224-1233.
PMID: 38802667 PMC: 11329372. DOI: 10.1038/s41565-024-01679-1.